Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $147.13 in the prior trading day, Repligen Corp (NASDAQ: RGEN) closed at $145.37, down -1.20%. In other words, the price has decreased by -$1.20 from its previous closing price. On the day, 0.7 million shares were traded. RGEN stock price reached its highest trading level at $149.66 during the session, while it also had its lowest trading level at $141.26.
Ratios:
Our goal is to gain a better understanding of RGEN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 62.05. For the most recent quarter (mrq), Quick Ratio is recorded 8.76 and its Current Ratio is at 10.44. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on February 10, 2025, initiated with a Buy rating and assigned the stock a target price of $200.
On December 17, 2024, Canaccord Genuity started tracking the stock assigning a Hold rating and target price of $165.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 ’24 when Hunt Anthony sold 24,246 shares for $139.67 per share. The transaction valued at 3,386,439 led to the insider holds 139,840 shares of the business.
Anthony Hunt bought 24,246 shares of RGEN for $3,386,311 on Nov 21 ’24. On Sep 10 ’24, another insider, Hunt Anthony, who serves as the Director of the company, sold 22,191 shares for $145.37 each. As a result, the insider received 3,225,927 and left with 139,840 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGEN now has a Market Capitalization of 8144601088 and an Enterprise Value of 8131719168. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.84 while its Price-to-Book (P/B) ratio in mrq is 4.04. Its current Enterprise Value per Revenue stands at 12.817 whereas that against EBITDA is 71.746.
Stock Price History:
The Beta on a monthly basis for RGEN is 1.20, which has changed by -0.2490443 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, RGEN has reached a high of $200.23, while it has fallen to a 52-week low of $113.50. The 50-Day Moving Average of the stock is -7.18%, while the 200-Day Moving Average is calculated to be -0.48%.
Shares Statistics:
The stock has traded on average 612.28K shares per day over the past 3-months and 759980 shares per day over the last 10 days, according to various share statistics. A total of 56.03M shares are outstanding, with a floating share count of 52.91M. Insiders hold about 5.57% of the company’s shares, while institutions hold 100.99% stake in the company. Shares short for RGEN as of 1740700800 were 3453504 with a Short Ratio of 5.64, compared to 1738281600 on 3304952. Therefore, it implies a Short% of Shares Outstanding of 3453504 and a Short% of Float of 7.21.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
